Agila Specialites Articles
Mylan signs $1.6bn deal to buy Agila injectables division
28 February 2013
News briefs: Drug majors eyeing Strides Arcolab unit; Astellas invests in oncology facility
20 August 2012
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
